Home/Filings/4/0001127602-18-029912
4//SEC Filing

Blome James 4

Accession 0001127602-18-029912

CIK 0001705843other

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 5:20 PM ET

Size

9.9 KB

Accession

0001127602-18-029912

Insider Transaction Report

Form 4
Period: 2018-10-08
Blome James
Chief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-10-08+200,000200,000 total
    Exercise: $14.24Exp: 2028-10-08Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The Stock Option was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months.

Issuer

Calyxt, Inc.

CIK 0001705843

Entity typeother

Related Parties

1
  • filerCIK 0001753563

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 5:20 PM ET
Size
9.9 KB